Interferon alfa-2b plus low dose cytarabine for the maintenance of remission in acute myeloid leukemia and advanced myelodysplastic syndrome

Charles A. Koller, Jörge E. Cortes, Emil J. Freireich

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Interferon alfa-2b plus low dose cytarabine for the maintenance of remission in acute myeloid leukemia and advanced myelodysplastic syndrome'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds